Rosuvastatin Tablets, USP, 10 mg, Packaged as: a) 30-count bottle (NDC 68788-7086-3); b) 90-count bottle (NDC 68788-7086-9), Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703.
Published April 12, 2023 · Recall initiated: March 23, 2023
Summary
FDA records drug Class II recall D-0519-2023, published April 12, 2023 and initiated March 23, 2023. Recalling firm: Preferred Pharmaceuticals, Inc.; Status: Ongoing; Reported quantity: a) 59 Bottles, b) 77 Bottles; Lot: a) Lot: F2022N, Exp. Date: 2/29/2024; b) Lot: F0322I, Exp. Date: 8/31/2023; Lot: J1322H, Exp. Date: 2/29/2024; Lot: K0222N, Exp. Date: 6/30/2024; Lot: L2322D and Lot: L2822J, Exp. Date:7/31/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
What to do
Voluntary: Firm initiated · Letter
Get an email if ROSUVASTATIN CALCIUM has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ROSUVASTATIN CALCIUM
- Manufacturer
- Preferred Pharmaceuticals, Inc.
- Distributor
- USA Nationwide
- Lot
- a) Lot: F2022N, Exp. Date: 2/29/2024; b) Lot: F0322I, Exp. Date: 8/31/2023; Lot: J1322H, Exp. Date: 2/29/2024; Lot: K0222N, Exp. Date: 6/30/2024; Lot: L2322D and Lot: L2822J, Exp. Date:7/31/2025.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDARosuvastatin Tablets 40mg, 30-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited,April 16, 2025
- FDAMontelukast Sodium Tablets, USP, 10 mg, packaged in: a) 30-count bottle (NDC 68788-9438-3); b) 60-count bottleApril 12, 2023
- FDARosuvastatin Tablets, USP, 5mg, 30-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NCApril 12, 2023
- FDAGlimepiride Tablets, USP, 2 mg, 90-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NCApril 12, 2023
- FDAPravastatin Sodium Tablets, USP, 20 mg, 90-count bottle, Rx only, Manufactured for: Accord Healthcare, Inc.,April 12, 2023
- FDAFinasteride Tablets, USP, 5 mg, packaged in: a) 30-count bottles (NDC 68788-6976-3); b) 90-count bottles (NDCApril 12, 2023
Questions about this recall
Was Rosuvastatin Tablets, USP, 10 mg, Packaged as: a) 30-count bottle (NDC 68788-7086-3); b) 90-count bottle (NDC 68788-7086-9), Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703. recalled?
Yes. FDA published recall D-0519-2023 on April 12, 2023. Reported hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ROSUVASTATIN CALCIUM.